Author

Bar Maron

Hebrew University of JerusalemORCID 0009-0000-7548-1628Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:bacteria (other)· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2

Frequent Co-Authors

Zvi HayoukaiD· 2 shared Bernardo AntunesiD· 1 shared Caroline ZanchiiD· 1 shared Christopher WitzanyiD· 1 shared Jens RolffiD· 1 shared Jonathan FriedmaniD· 1 shared Paul R. JohnstoniD· 1 shared Roland R. RegoesiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Zvi HayoukaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJul 6, 2026

Cross-Resistance Limits the Ability of Antimicrobial Peptide Combinations to Delay Resistance Evolution

Bar Maron, Shir Mor, Jonathan Friedman, Zvi Hayouka

This study shows that cross-resistance, not mode of action, determines the effectiveness of antimicrobial peptide combinations in delaying resistance evolution.

DOI 10.64898/2026.07.05.736553

bacteria (other)experimental assay

𝕏 PostBluesky

MicrobiologyPLoS BiologyPeer-reviewedJul 2, 2024

The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures

Bernardo Antunes, Caroline Zanchi, Paul R. Johnston…·Jens Rolff

This study shows that random antimicrobial peptide mixtures reduce resistance evolution in Pseudomonas aeruginosa compared to single peptides, preventing cross-resistance and maintaining drug sensitivity.

25 citationstop 3%

bacteria (other)experimental assay

𝕏 PostBluesky